4Flu - an individual based simulation tool to study the effects of quadrivalent vaccination on seasonal influenza in Germany
Open Access
- 3 July 2014
- journal article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 14 (1) , 365
Abstract
Influenza vaccines contain Influenza A and B antigens and are adjusted annually to match the characteristics of circulating viruses. In Germany, Influenza B viruses belonged to the B/Yamagata lineage, but since 2001, the antigenically distinct B/Victoria lineage has been co-circulating. Trivalent influenza vaccines (TIV) contain antigens of the two A subtypes A(H3N2) and A(H1N1), yet of only one B lineage, resulting in frequent vaccine mismatches. Since 2012, the WHO has been recommending vaccine strains from both B lineages, paving the way for quadrivalent influenza vaccines (QIV).Keywords
This publication has 66 references indexed in Scilit:
- Leveraging social networks for understanding the evolution of epidemicsBMC Systems Biology, 2011
- Multiple Genotypes of Influenza B Virus Circulated between 1979 and 2003Journal of Virology, 2004
- Influenza-Associated Hospitalizations in the United StatesJAMA, 2004
- Mapping the Antigenic and Genetic Evolution of Influenza VirusScience, 2004
- Tumor Necrosis Factor Alpha Exerts Powerful Anti-Influenza Virus Effects in Lung Epithelial CellsJournal of Virology, 2002
- The evolution of human influenza virusesPhilosophical Transactions of the Royal Society B: Biological Sciences, 2001
- Influenza types and patient populationThe Lancet, 1995
- The estimation of the basic reproduction number for infectious diseasesStatistical Methods in Medical Research, 1993
- Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983Virology, 1990
- AN INFLUMZA SIMULATION MODEL FOR IMMUNIZATION STUDIESAmerican Journal of Epidemiology, 1976